All Curated Mutation Sites in HCV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HCV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
5'UTR
  
C
  
E1
  
E2
  
NS2
  
NS3
  
NS4B
  
NS5A
  
NS5B
  
p7
  
Protease
  

Keyword: HCV Infection-24341898
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 24341898 V321I
NS5B
NS5B
HCV Infection
D
G
R
S
C
View
2 24341898 M426L
NS5B
NS5B
HCV Infection
D
G
R
S
C
View
3 24341898 Y448H
NS5B
NS5B
HCV Infection
D
G
R
S
C
View
4 24341898 Y452H
NS5B
NS5B
HCV Infection
D
G
R
S
C
View
5 24341898 M28V
NS5A
NS5A
HCV Infection
D
G
R
S
C
View
6 24341898 L31M
NS5A
NS5A
HCV Infection
D
G
R
S
C
View
7 24341898 H58P
NS5A
NS5A
HCV Infection
D
G
R
S
C
View
8 24341898 L159F
NS5B
NS5B
HCV Infection
D
G
R
S
C
View
9 24341898 C316N
NS5B
NS5B
HCV Infection
D
G
R
S
C
View
10 24341898 R465G
NS5B
NS5B
HCV Infection
D
G
R
S
C
View
11 24341898 V499A
NS5B
NS5B
HCV Infection
D
G
R
S
C
View
12 24341898 L28V
NS5A
NS5A
HCV Infection
D
G
R
S
C
View
13 24341898 Q54H
NS5A
NS5A
HCV Infection
D
G
R
S
C
View
14 24341898 Y93H
NS5A
NS5A
HCV Infection
D
G
R
S
C
View
15 24341898 I280V
NS5A
NS5A
HCV Infection
D
G
R
S
C
View
Contents
Description

The table shows all curated mutation sites of HCV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.